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Molecular forceps from combinatorial libraries prevent the 
farnesylation of Ras by binding to its carboxyl terminus 
Dennis L Dong, Ruiping Liu, Rosemarie Sherlock, Michael H Wigler and 
H Peter Nestler 
Introduction: Ras is one of the major oncogenes. In order to function properly it 
has to undergo post-translational processing at its carboxyl terminus. It has 
been shown that inhibitors of farnesyl transferase, the first enzyme in the 
processing chain, can suppress the transforming activity of oncogenic Ras. 
Results: We have identified molecular forceps, branched peptidic molecules, 
from combinatorial libraries that bind to the carboxyl terminus of Ras and 
interfere with its farnesylation without inhibiting the farnesyl transferase. The 
active molecules were selected by a screening against the carboxy-terminal 
octapeptide of Ras. 
Conclusions: The implications of our findings are twofold. First, we 
demonstrate that it is possible to prevent enzymatic transformations by blocking 
the enzyme’s access to its substrate using a synthetic small molecule to mask 
the substrate. Second, we show that it is feasible to derive molecules from 
combinatorial libraries that bind a specific epitope on a protein by selecting 
these molecules with the isolated peptide epitope. 
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Introduction 
Knowledge of the determinants of noncovalent intermole- 
cular interactions in biological systems can sometimes be 
used to modulate biological activities by chemical inter- 
vention. Past efforts have been hampered by the need to 
synthesize and investigate structures individually, but the 
recent development of combinatorial library techniques 
has lifted this restriction. Combinatorial chemistry allows 
the simultaneous controlled synthesis of thousands to mil- 
lions of compounds, the subsequent simultaneous assay of 
their activity and the determination of the structure of 
active compounds. Virtually any sequence of chemical 
reactions can be employed to synthesize diverse and 
complex libraries of molecules. Such libraries have been 
mostly used for drug discovery and optimization [l-7] 
(M. Lebl and 2. Leblova, Dynamic database of references 
in molecular diversity; http://www.Sz.com/divinfo/) but 
they have also found application in the studies of molecu- 
lar recognition and the development of artificial receptors 
[S-12]. In our initial studies, WC elaborated libraries of 
small molecules with branched peptidic structure (‘mol- 
ecular forceps’) and showed examples of highly specific 
interactions between these molecular forceps and peptide 
ligands in organic solvents [13-151. Here, we describe how 
we have employed these systems to derive artificial 
binding pockets that bind proteins of physiological impor- 
tance at specific functional sites in aqueous media. Such 
moieties can be used as synthetic surrogates for mono- 
clonal antibodies, diagnostics to detect proteins in western 
blots or in cells, affinity agents on supports to allow the 
convenient purification of protein or agents that modulate 
the biological function of proteins by preventing their 
physiological interactions. In the present case we use such 
molecules to inhibit the processing of Ras proteins at their 
carboxyl termini. 
We have chosen Ras as the first target protein for several 
reasons. Ras proteins play a central role in normal cellular 
physiology and mutant Ras proteins in the pathophysiol- 
ogy of tumors [16,17]. Moreover, much is known about 
the structure and function of Ras proteins. They are 
required for the transduction of signals from many mem- 
brane receptors, including tyrosine kinases and some G- 
protein-linked receptors, and are representatives of a 
large and highly conserved family of guanine-nucleotide- 
binding proteins, the Ras superfamily, that participate in 
a wide variety of cellular phenomena. Point mutations 
that activate the oncogenic potential of Ras genes are 
commonly found in human tumors. These point muta- 
tions usually cause amino-acid substitutions at either 
position 12 or 61, leading to impaired GTP hydrolysis. 
Ras proteins are initially synthesized in the cytoplasm, 
where they undergo a series of post-translational modifl- 
cations at their carboxy-terminal sequence. the CaaX box 
(where ‘C’ is cysteine, ‘a’ an aliphatic amino acid and ‘X’ 
either serine or methionine). resulting in their farnesyla- 
tion, and subsequent cleavage of the terminal tripeptide 
and carboxy-methylation [l&19]. The processed proteins 
become localized to the cell membrane, a step that is 
essential for their functioning [20-Z?]. 
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Oncogenic Ras proteins have been considered to be logical 
targets for the development of cancer therapeutics. One 
approach has been to find agents that block Ras processing 
by inhibiting farnesyl transferase (FTase) [23-261. In fact, 
such agents can induce morphological reversion of cells 
transformed by Ras at concentrations that do not arrest 
normal cell growth. The results with FTase inhibitors 
suggest that, in general, the level of an inhibitor needed to 
block the transforming activity of Ras will not necessarily 
reduce normal Ras activity below levels sufficient for 
normal cell growth [23,24,27]. Moreover, nonfarnesylated 
oncogenic H-Ras-Vail2 has been shown to sequester Raf 
to the cytosol [B]. FTase inhibitors might therefore be 
generally useful as anticancer agents. One potential obsta- 
cle to using such agents as drugs is that they might block 
the farnesylation of other critical proteins in humans, such 
as the y subunit of transducin and nuclear lamins. 
On the other hand, a small molecule that binds to the car- 
boxy1 terminus of a particular Ras might prevent FTase 
from acting upon this Ras without inhibiting the activity 
of the transferase on other substrates. Indeed, the precise 
CaaX sequences and the two amino-acid residues preced- 
ing them distinguish the members of the Ras family from 
each other, and from other substrates for farnesyl and 
geranyl geranyl transferases. Our ability to find synthetic 
molecular forceps from encoded combinatorial libraries 
that distinguish peptides differing by single amino-acid 
substitutions in organic phase [13] raised our hopes of 
finding molecules that selectively bind to the CaaX box of 
one particular Ras protein in aqueous phase and therefore 
might specifically prevent the processing of Ras. 
Results and discussion 
Preparation of the encoded combinatorial library of 
molecular forceps 
In earlier studies, we and others could show that the recog- 
nition of peptides and their discrimination with single 
Figure 1 
amino-acid resolution does not require complex macromol- 
ecular structures but can be achieved with molecules that 
display two short peptide chains on a rigid scaffold [13,29]. 
We discovered that molecules presenting two tripeptides 
linked by a flexible pentamethylene linker can bind pen- 
tapeptides, although with less affinity and specificity than 
the rigid molecules [15]. These early experiments were 
performed in organic solvents. We expected, however, that 
similar interactions should occur in aqueous surroundings 
and that molecular forceps should be able to recognize epi- 
topes on physiologically important proteins and interfere 
with their biological functions. 
As it was not obvious whether a flexible or rigid structure 
would be advantageous for the interactions with a particu- 
lar target, we used both the rigid chenodeoxycholic acid 
scaffold with a glycine spacer (Ll) and a flexible lysine 
(LZ) as cores to generate a symmetrical library of molecu- 
lar forceps (MF) on Tentagel beads. We also used a tri- 
lysine core (L3) to study the influence of increased 
molecular surface on the strength of the interactions. 
These molecular forceps contained glycine and both 
enantiomers of alanine, vdline, serine, proline, asparagine, 
glutamine and lysine at the four variable amino-acid posi- 
tions (Figure 1). The library was generated using split syn- 
thesis [30,31] and the reaction history of each bead was 
recorded using the molecular catechol tags described by 
Nestler, Still and coworkers [32]. 
Ras proteins and the carboxy-terminal octapeptide of Ras 
bind to members of the library 
Antibodies coupled to alkaline phosphatase have been fre- 
quently used in the screening of combinatorial libraries for 
beads binding to proteins [30,33]. This procedure is cum- 
bersome, however, and requires multiple steps that might 
be unsuitable for the detection of interactions with lower 
affinities. Proteins have, therefore, sometimes been 
labeled directly with dyes, especially fluorescein, that can 
r 
(-1 Tetrapeptide library with 15 different amino acids in each position (50,625 members) 
l Tentagel resin beads Chemistry 8 Biolog) 
1 Branched molecular forceps library with three different linkers The tetrapeptide libraries 
consisting of 15 L- and o-amino acids at each 
position were synthesized using split 
synthesis. The structures of the three different 
linkers are shown, one with chenodeoxy cholic 
acid (Ll, steroid) as a scaffold, two others (L2 
and L3) using lysines as flexible 
pentamethylene linkers. The total diversity of 
the library is 3 x 1 54= 151,875 molecules. 
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Figure 2 
Investigation of resynthesized molecular 
forceps on the activity of FTase. Selected 
molecular forceps from peptide and protein 
screenings were resynthesized. They were 
assayed for their effects on the activity of yeast 
FTase using purified H-Ras-Vall2 protein as 
substrate. (a) The list of both positive 
(MFl-MF7) and negative (MFB) molecular 
forceps, and their selections; MFl -MF3 were 
selected from the His-tagged CaaX-peptide 
screening, and MF4-MFB were chosen from 
FM-GST-H-Ras-Val12 protein screening. 
(Uppercase letters define L-amino acids, 
lowercase letters are the D-enantiomers.) 
(b) FTase activity assay in the presence of 
different concentrations of molecular forceps. 
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be detected directly [34,35]. In our screenings, we 
employed fluorescein-5maleimide (FM) to conjugate flu- 
orescein to purified glutathione S-methyl transferase 
(GST) and a GST-H-Ras-Val12 fusion protein. First, 
about 7000 library beads were extensively incubated with 
FM-GST and the green fluorescent beads were removed 
to eliminate false positive binders. The remaining 
unstained beads were then incubated with FM-GST-H- 
Ras-Vall2. The green fluorescent beads were picked up 
and the encoding tags were analyzed using gas chromatog- 
raphy (GC) [32]. .4mong the about 7000 library beads used 
in the screening, we found 65 relatively strong green 
beads. From GC analysis, we obtained 30 readable 
sequences (data not shown). All these positive molecules 
have either LZ or L3 as core template, and no molecules 
based on the Ll scaffold were found. From the 30 
sequences, we selected four molecular forceps, (p-E-K- 
S),L3 (‘MF4’), (Q-E-k-p),L3 (‘MFS), (S-k-K-E),L3 
(‘MF6’), and (f-p-K-s),L3 (‘MF7’) for further studies 
(single-letter amino-acid code is used; lower case letters 
are D enantiomers and upper case letters are L enan- 
tiomers). We decided to use one molecular forceps from a 
bead that failed to bind to FM-GST and FM-GST-H- 
Ras-Vall2, (F-k-G-F),L3 (‘MF8’), as a putative negative 
control (Figure Za). 
Selecting molecular forceps from libraries for Ras binding 
does not insure that these forceps will recognize the car- 
boxy1 terminus of Ras. We therefore sought to screen mol- 
ecular forceps libraries with the isolated carboxy-terminal 
peptide from Ras to select molecular forceps chat bind this 
epitope specifically. 
W’e and others have used the dye-labeling strategy for the 
screening of small peptides against receptor libraries in 
organic solutions [13,15,36,37]. When hydrophilic dyes are 
conjugated with short peptides, however, the characteristics 
of the dye dominate in the screening and only library 
members interacting with the dye are selected [38]. To cir- 
cumvent this problem, we have developed a method using 
the hexahistidine tag (His tag) on peptides and proteins to 
detect binding on beads [39]. The His tag interacts with 
ions of transition metals, such as copper. Copper ions can be 
used to catalyze the oxidation of benzidine to the blue dye 
Benzidine Blue. Consequently, beads that bind to the His- 
tagged peptides or proteins can therefore be distinguished 
by their purplish brown color when appropriately treated. 
We linked the His tag to the carboxy-terminal decapeptide 
of H-Ras to create a binding site for copper ions. The 
resulting peptide had the sequence HHHHHH-GSMSCK- 
CVLS (using single-letter amino-acid code). We screened 
about 10,000 library beads against this His-tagged Ras 
carboxy-terminal peptide and obtained 30 different struc- 
tures after decoding of the selected beads. Figure 2a lists 
those ‘hit’ molecules, (v-f-E-e-)jL3 (‘MFL’), (V-E-F-E-),L3 
(‘MFZ’), and (f-G-F-E-),L3 (‘MF3’), that we chose for 
further studies. Interestingly, as in the protein assay, most 
positive molecular forceps contained the trilysine linker 
(L3), and the remainder were two-arm lysine forceps (LZ). 
As L3 was the predominant scaffold in the peptide as well 
as the protein screening, we focused our attention on mol- 
ecular forceps based on this motif. We cannot offer any con- 
vincing rationalization for the failure to observe the steroid 
scaffold in our screening, but there are many possible expla- 
nations: failure of synthesis, mechanical collapse of the 
beads around the steroids, adhesion of the steroid to the 
hydrophobic core of the beads or collapse of the peptide 
chains on the steroid template in water. 
Molecular forceps that bind the Ras carboxy-terminal 
sequence impede the farnesylation of Ras 
Three molecular forceps from the His-tagged peptide 
assay and four forceps from the protein screen (MFl- 
MF7), as well as one from a bead that did not bind (MF8) 
136 Chemistry & Biology 1999, Vol 6 No 3 
Figure 3 
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Effect of MF3 on the farnesylation of different 
CaaX peptides. N-Biotinylated peptides 
containing the CaaX motif were synthesized 
and used as substrates for FTase assays in 
presence of different concentrations of MF3. 
Sequence names with two proteins designate 
chimeric sequences, (i.e. H-Ras + K-Ras). 
were resynthesized on Tentagel-NH2 to retest and 
confirm their interactions with the Ras protein. All posi- 
tive forceps (MFl-MF7) bind to the fluorescein-labeled 
GST-Ras (data not shown). For further studies in solu- 
tion we prepared molecular forceps, cleaved them frorn 
the resin and purified them using high-performance 
liquid chromatography (HPLC). 
The resynthesized molecular forceps (MFl-MF8, except 
MFS, which was not soluble) were tested for the inhibi- 
tion of farnesylation by yeast FTase (the expression plas- 
mids were the generous gift of F. Tamanoi) [40]. As 
expected, MF8, our negative selection, showed no inhibi- 
tion on the farnesylation of Ras protein (Figure Zb). MF6 
and hlF7 from the protein screening also showed no 
effect, as did MFl. which we had obtained from the 
peptide screening. MF4 shows a weak impact on the far- 
nesylation with an IC,,, higher than 1 mM. The two mol- 
ecular forceps 1\/IFZ and MF3 from the screening against 
the peptide epitope provided the best inhibition 
(Figure Zb). The IC,,, values for MF2 and MF3 are about 
400 /.&I and 100 @I, respectively. Additional experiments 
showed that neither the two-armed forceps derived from 
MF3 (which corresponds to the molecular forceps based 
on L2) nor the isolated tetrapeptide arm of MF3 has any 
effect on the farnesylation of Ras. 
Impeding the farnesylation with MF3 is sequence dependent 
As discussed in the introduction, many cellular proteins 
are processed by FTase. We reasoned that, if our forceps 
inhibited the farnesylation of Ras by binding to its car- 
boxy1 terminus, they might not inhibit the processing of 
other proteins by FTase. To test the specificity of MF3, 
we therefore used four CaaX-containing peptides, derived 
from Lamin B, K-Ras B and H-Ras, as well as a chimera of 
the H-Ras and K-Ras sequences (‘H-Ras + K-Ras’; 
Figure 3), which were biotinylated at their amino termini, 
as FTase substrates in the presence of varying concentra- 
tions of MF3. Satisfyingly, molecular forceps hIF3 showed 
different effects on the farnesylation of these substrates 
by yeast GST-FTase. Although MF3 has no influence on 
the modification of the Lamin B peptide at concentrations 
up to 1 mM, it shows a weak effect on the K-Ras B 
peptide, and a stronger impact on the H-Ras/K-Ras B 
chimera. hlF3 strongly impedes the farnesylation of 
biotinylated H-Ras peptide with an IC,, of about 100 PM, 
which is the same as we observed when using Ras protein 
as the substrate (Figure 3). Preliminary experiments with 
purified FTase from bovine brain [41] showed a similar 
pattern. (The mammalian FTase was a generous gift from 
P. Casey.) These results indicate the inhibition of farnesy- 
lation is sequence dependent and not dependent on the 
presence of the Ras protein structure. 
During the course of preparing the biotinylated peptides 
for our sequence-specificity studies, we noticed that the 
solubility of some biotinylated peptides in aqueous media 
was poor. We therefore constructed His-tagged green fluo- 
rescent protein (GFP) with more than a dozen carboxy- 
terminal epitopes and tested these in farnesylation assays. 
As shown in Figure 4, the negative molecular forceps, 
MF8, shows no inhibition on the farnesylation with any 
CaaX fusion protein (Figure 4b). A commercial FTase 
inhibitor, the farnesylpyrophosphate analog FPT-II [42], 
shows broad inhibition of the activity of FTase on differ- 
ent CaaX fusion proteins, although the strongest impact 
seems to be on the farnesylation of H-Ras (Figure Id). 
h/IF3 shows again the strong preference for the GFP-H- 
Ras-CaaX protein (Figure 4~). 
Our studies show that the forceps can recognize more than 
the carboxy-terminal tetrapeptide of farnesylation sub- 
strates. This is not surprising given that our original 
screening utilized a specific octapeptide epitope. 
hlF3 does not bind to FTase 
To confirm further that the inhibition of farnesylation of 
GFP-CaaX proteins is due to the binding of the molecular 
Figure 4 
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Figure 5 
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Generation of His-tagged GFP-CaaX fusion proteins as substrates of 
FTase and the effect of molecular forceps on their farnesylation activity. 
His-tagged GFP-CaaX fusion proteins were generated and used as 
substrates for the FTase assay in the presence of 250 uM of molecular 
forceps MF8 or MF3 or 2.5 uM of the farnesylpyrophosphate analog, 
FPTII. (a) List of His-tagged GFP-CaaX fusion proteins and their 
carboxy-terminal sequence. (b) FTase assay in the presence of 
negative molecular forceps MF8. (c) FTase assay in the presence of 
molecular forceps MF3. (d) Ffase assay in the presence of the FTase 
inhibitor FPTII. 
forceps to their CaaX sequence and not to binding of 
FTase, we performed in aitro binding assays by incubating 
different GFP-CaaX fusion proteins with biotinylated 
MF3. We incorporated a biotin label to enable precipita- 
tion of protein-forceps complexes. These biotin labels 
were incorporated by modifying the carboxy-terminal part 
of the forceps with PAla-Glu-Lys(Biotin)-PAla-OH. The 
proteins were incubated in solution with the biotinylated 
forceps and the complexes were precipitated with avidin 
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MF3 binds strongly to the carboxy-terminal sequence of H-Ras. The 
binding strength of MF3 to various GFP-CasX fusion proteins 
correlates with the inhibitory activity in the farnesylation assays. 
(a) Biotinylated MF3 was incubated with various His-tagged GFP-CaaX 
fusion proteins, and the bound proteins were precipitated with avidin 
beads, analyzed by SDS-PAGE, and detected by anti-(His), antibody. 
(b) FTase inhibition assay of different His-tagged GFP-CaaX fusion 
proteins with MF3. The concentration of MF3 used in the assay was 
250 PM. Biotinylated and nonbiotinylated MF3 show the same inhibition. 
sepharose beads. After elution of the bound proteins from 
the beads and gel electrophoresis, we detected the pro- 
teins using western blotting with the suitable antibodies. 
As demonstrated and discussed earlier, MF3 affects the 
farnesylation of H-Ras most, followed in extent by 
H-Ras/Lamin B, and K-Ras/H-Ras, and so forth, as shown 
in Figure 5b. We found that the in r&o binding strength 
of MF3 to the GFP-CaaX proteins correlates with its 
inhibitory activity. .4s shown in Figure Sa, the molecular 
forceps MF3 bind strongly to the CaaX sequence of 
H-Ras, and distinguish the different CaaX sequences, a 
pattern that is reflected in the inhibitory effect on the far- 
nesylation of these sequences. To test the binding of MF3 
to FTase, biotinylated MF3 was incubated with GST-H- 
Ras-\‘a112 and GST-FTase. Although MF3 clearly inter- 
acts with GST-H-Ras-Vall2 at a concentration of 
250 pM, we did not observe any binding to yeast FTase 
(Figure 6). These results suggest that, although MF3 can 
bind to Ras, it fails to bind FTase, implying that MF3 
does not act as an enzyme inhibitor, but that its activity is 
caused by its interaction with the substrate. 
In recent years, the use of combinatorial libraries has 
opened novel ways to generate artificial receptors. Our 
studies started from three assumptions: first, we should be 
able to find forceps that selectively recognize peptides in 
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MF3’s effect on the farnesylation of H-Ras is due to its binding of the 
carboxy-terminal domain and not binding to FTase. GST, GST-FTase 
and GST-H-Ras-Vall2 were incubated with 250 uM of biotinylated 
MF7 or MF3. Proteins bound to the biotinylated molecular forceps were 
precipated with avidin beads, analyzed by SDS-PAGE and detected 
with primary anti-GST antibody and secondary horseradish peroxidase 
conjugated anti-rabbit antibody. MF7 is one molecular forceps that was 
found to bind Ras but does not inhibit its farnesylation. 
aqueous solution; second, these forceps should recognize 
the peptide as an epitope embedded in a protein; finally, 
epitope-binding forceps should be capable of modulating 
the biological function of the target proteins. Using a 
receptor design that we had established before, we gener- 
ated a library of molecular forceps and screened them 
Figure 7 
against the farnesylation site of the Ras protein. Our results 
prove the validity of our assumptions. Although the actual 
numbers of molecules tested might be too low for a final 
assessment of the most efficient screening strategy, we 
clearly demonstrate that artificial receptor molecules from 
libraries can specifically bind the epitopes of proteins and 
are able to modulate biochemical processes associated with 
these proteins. 
In our present application we have used the carboxy-ter- 
minal CaaX sequence of Ras. It is unlikely that this is the 
only peptide epitope that will yield to this type of 
approach. Biological systems have evolved to recognize 
simple amino-acid motifs, such as the RGD loop involved 
in fibronectin recognition, the MGCXXS sequence 
involved in myristilation, and SH2 and SH3 recognition 
peptides, to mention but a few. There are many applica- 
tions that can be conceived for artificial receptor mol- 
ecules that bind such epitopes. Besides the potential 
therapeutic application of these molecules, they can, with 
the appropriate modifications, be useful tools for the 
purification or diagnostic detection of proteins, in western 
blots or in a physiological environment. 
Although our studies give the first indication that such 
applications may be possible, our molecular forceps and 
the strategies to identify them are far from offering a com- 
plete and elaborated system. There are many obstacles 
that we face on the way to the various applications. For 
example, the affinity of our forceps is low and requires 
their use in high concentrations. Beyond working towards 
higher affinities, the specificity of the interactions will 
have to be improved. In the course of such improvements, 
we will also face the challenge to generate structures that 
Chemstry & Biology 
Artificial synthetic small molecules can behave 
like an antibody to bind to the targeted 
epitope of protein specifically. MF3, the 
positive molecular forceps selected from our 
encoded peptidic combinatorial library, can 
specifically bind to the carboxyl terminus of 
Ras and prevent its farnesylation. It recognizes 
the epitope of a particular protein and 
therefore inhibits the farnesylation of Ras 
more selectively than inhibitors that interact 
with the enzyme. 
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can easily penetrate cells. To date we do not know 
whether the classical modifications employed by medici- 
nal chemists will allow us to create molecular forceps that 
can pass the cell membrane or whether we will need a 
completely different receptor design. Nevertheless, we 
believe that our results give proof of the viability of the 
concept and can be the basis for studies that strive to gen- 
erate new forceps with improved properties. 
Significance 
In recent years, combinatorial libraries have become a 
major tool in drug discovery and drug development. Fur- 
thermore, encoded combinatorial libraries have been 
used to disclose ligands for well-designed synthetic macro- 
cyclic host molecules and to elucidate their specificities 
for peptide sequences. These studies led, via receptors 
with more flexibility, to simple host molecules without 
elaborate design that are accessible to combinatorial syn- 
thesis. We have generated libraries of molecular forceps, 
receptor molecules of branched peptidic structure, and 
screened them for molecules that bind to the carboxy-ter- 
mitral farnesylation site of the Ras protein. 
Ras proteins play a central role in signal transduction 
and the mutated forms of Ras are commonly found in 
human tumors. They undergo a complex post-transla- 
tional processing that is crucial for their functioning. The 
inhibition of the farnesylation of the carboxyl terminus, 
the first step in the processing sequence, has been shown 
to be a very effective way to revert the transformed phe- 
notype of cells containing mutated Ras proteins. 
We show that molecular forceps that bind to the car- 
boxy1 terminus of Ras can also impede the farnesylation 
of Ras by FTase. Our findings give proof for a new 
concept, as we interfere with the enzymatic process not 
by inhibiting the enzyme but by masking the substrate 
epitope with a small molecule (Figure 7). Many other 
epitopes are subject to biochemical processing and could 
be targeted in the same fashion, including glycosylation 
sites, myristilation motifs or even phosphorylation sites. 
Our strategy might allow the selective binding of such 
proteins and modulation of their activities. 
Material and methods 
Generation of the molecular forceps libraries 
The encoded forceps library was generated using the split-mix strategy 
[30,31 I. Tentagel-NH, 15 g; (RAPP Polymere, Tubingen, Germany, 
90 urn bead diameter, 0.29 mmolelg of NH,) was used as solid support 
and the amino acids were attached using standard FmoclBoc (fluorenyl- 
methoxycarbonyl/butyloxycarbonyl)-peptide solid phase mediated by 
HOBt/DIC (hydroxybenzotriazoleldiisopropylcarbodiimide) [43]. The 
completeness of the couplings was monitored with Bromophenol Blue 
[44]. The catechol tags [32] were attached as carboxylic acids using 
HOBt/DIC using approximately lo/, of the available amino groups for 
each tag. The structures of the linking core (Ll-L3) are shown in 
Figure 1. A combination of 15 different amino-acids (glycine and the D/L 
enantiomeres of valine, phenylalanine, serine, glutamine, glutamic acid, 
lysine and proline) was used for the structural diversity. After four split-mix 
coupling cycles, we generated a library of 3 x 1 54= 151,875 members. 
The library was deprotected by treatment with 20% piperidine/DMF and 
95% TFA / 2.5% water / 2.5% thioanisole and stored at 4°C. 
Peptide synthesis and resynthesis of positive molecular forceps 
Selected molecular forceps were resynthesized on Tentagel resin or on 
Wang resin (Novabiochem) for molecular forceps used in solution 
studies. For the solution-binding studies biotin was incorporated to 
allow for the handling of the forceps. This was achieved by derivatizing 
the carboxy-terminal carboxylic acid of the molecular forceps with 
PAla-Glu(OtBu)-Lys(Biotin)-PAlaOH. Short linear peptides required 
in the solution studies were also prepared on Wang resin, All these 
batch syntheses were performed on a RAININ Symphony multiple 
peptide synthesizer using standard Fmoc/Boc-peptide chemistry with 
HBTU-mediated couplings. The products were purified using HPLC 
using a WATERS Delta Prep 3000 with 15 u Cl8column 
(25 mm x 300 mm) and a linear gradient of 0.1% TFAlwater to 0.10/o 
TFA/70% CH,CN/water and were characterized by MALDI-TOF mass 
spectrometry and peptide sequencing. 
Expression and purification of proteins 
The DNA constructs coding for the proteins were cloned into the appro- 
priate expression vectors and expressed in f. co/i. GST and GST-H- 
RasVal12, and GST-yeast FTase [40] were purified according to the 
manufacturer’s protocols through glutathione-agarose columns (Phar- 
macia BioTech). His-tagged GFP [45] and its fusion proteins with the 
various CaaX peptides were purified by affinity chromatography through 
nickel-loaded sepharose [46]. The proteins had the octapeptide HHHH- 
HHGG fused to the amino terminus of GFP and the peptide sequences 
listed in Figure 4 fused to the carboxy-terminal amino acid of GFP. 
Screening of the molecular forceps libraries with His-tagged 
Ras peptide 
The peptide HHHHHH-GSMSCKCVLS was incubated with library 
beads in 50 mM Tris at pH 8.0 room temperature overnight. The bead 
suspension was then equilibrated with a solution of copper sulfate 
and washed to remove excess of His-tagged ligands and copper ions. 
After addition of dilute solutions of benzidine and hydrogen peroxide, 
beads interacting with the His-tagged ligands develop a brown color 
which increases over time [39]. The brown/dark beads were picked 
under a dissecting microscope (30-fold magnification) and decoded 
using GC analysis [32]. 
Screening of the molecular forceps libraries with fluorescein- 
labeled Ras protein 
Purified GST and GST-H-RasVall2 proteins were labeled at their 
sulfhydryl groups with fluorescein-5-maleimide following the manufac- 
turer’s guidelines (Pierce Chemical Company) using a buffer containing 
20 mM sodium phosphate pH 7.0, 150 mM NaCI, and 5 mM EDTA. 
About 7000 forceps library beads were first incubated with FM-GST 
(after blocking with binding buffer containing 20 mM sodrum phos- 
phate pH 7.0, 500 mM NaCI, 0.1% Tween-20, 0.02% NaN,, and 
5mg/ml bovine serum albumin (BSA)), and green fluorescent beads 
(-350 beads, -5% of total) were removed. The remaining beads were 
incubated with FM-GST-H-Ras-Vall2, washed with the binding buffer 
three times, and examined under the microscope. The positive beads 
were picked up (65 of -6600 beads, 0.9% of total), washed and 
decoded using GC analysis [32]. 
Reconfirming the binding of forceps molecules to the Ras 
protein 
The positive forceps molecules were synthesized on the Tentagel 
beads, The beads were washed several times with water and incu- 
bated with the binding buffer containing bovine serum albumin. Then 
the beads were equilibrated with FM-GST-H-RasVall2 for 2 h. After 
washing with the binding buffer three times, they were examined under 
the dissecting microscope. 
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FTase inhibition assay - filter assay for proteins 
To assay the farnesylation of protein substrates, we employed a precip- 
itation assay. The FTase assay was carried out according to the proto- 
col described by Casey and coworkers 1411 with the following 
modifications. 5 pg of l-i-Ras or GFP-CaaX fusion proteins and the 
test compounds were mixed in 40 PI of transferase buffer (final buffer 
concentration: 50 mM Tris-HCI, pH 7.7, 20 mM KCI, 5 mM MgCI,, 
5 PM &Cl,, 2 mM Dll and 0.5 mM Zwittergent 3-l 4) and preincu- 
bated on ice for 10 min. Enzyme solution (10 pl; containing 0.1 pg of 
yeast GST-FTase [41]) and 0.1 pCi [sH]-FPP/FPP (1:2) were added 
and incubated at 37“C for 30 min. The reaction was stopped by addi- 
tion of 250 pl of 4% SDS. After 20 min at room temperature, 250 pl of 
30% trichloroacetic acid (TCA) were added, vortexed and incubated at 
room temperature for 30 min. The mixture was filtered through a mem- 
brane (Schleicher & Schuell AE91, 25 mM, 0.8 Jo). The membrane was 
washed three times with 1 ml of 4% SDS and 6% TCA, followed by 
1 ml of 6% TCA (twice). The extent of incorporated radioactivity on the 
membrane was quantified by scintillation counting. 
FTase inhibition assay - scintillation proximity assay for 
peptides 
To assay the farnesylation of biotinylated peptides, we employed a 
scintillation proximity assay. The scintillation proximity assay of FTase 
was carried out according to the manufacturer’s protocol (Amersham 
Life Science) using biotinylated CaaX peptides as substrates [471. The 
biotinylated peptides (10 pmol) were farnesylated for 20 min in the 
assay buffer (50 mM Hepes, 30 mM MgCI,, 20 mM KCI, 5 mM Dn, 
0.01% Triton X-100, pH 7.5) with 0.1 pCi PHI-FPP and 0.1 pg of 
yeast GST-FTase [41]. The peptides were then precipitated with 
‘STOP/bead reagent’ and the incorporated radioactivity on the beads 
was quantified by scintillation counting. 
In vitro binding assay between the forceps molecules and 
GST-fusion proteins 
GST, GST-Ffase, GST-H-Ras-Vall2 or GFP-CaaX fusion proteins 
(6 pg) were mixed with biotinylated molecular forceps (final concentra- 
tion 250 PM) in the binding buffer containing 50 mM Tris, pH 7.5, 
100 mM NaCI, 4 mg/ml ovalbumin, 1 mg/ml gelatin in a final volume of 
40 ~1, and incubated on ice for 2 h. Then 100 @I of avidin-sepharose 
beads which had been equilibrated with the binding buffer were added 
and incubated for 30 min with constant shaking. The beads were 
washed with the binding buffer three times, and finally resuspended in 
80 PI of SDS sample buffer. The supernatant was loaded onto a 10% 
SDS-polyacrylamide gel, and the GST bearing proteins were detected 
using western blotting using primary anti-GST antibody and horseradish 
peroxidase-conjugated secondary anti-rabbit antibody. The GFP-CaaX 
fusion proteins were detected using primary anti-(His),-antibody and 
horseradish peroxidase-conjugated secondary anti-rabbit antibody. 
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